SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017985
Filing Date
2019-05-09
Accepted
2019-05-09 16:11:46
Documents
69
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20190331.htm   iXBRL 10-Q 2192947
2 EX-31.1 dvax-ex311_9.htm EX-31.1 17792
3 EX-31.2 dvax-ex312_6.htm EX-31.2 17777
4 EX-32.1 dvax-ex321_7.htm EX-32.1 6048
5 EX-32.2 dvax-ex322_8.htm EX-32.2 6328
  Complete submission text file 0001564590-19-017985.txt   8153687

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dvax-20190331.xsd EX-101.SCH 51437
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20190331_cal.xml EX-101.CAL 55292
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20190331_def.xml EX-101.DEF 199823
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20190331_lab.xml EX-101.LAB 433717
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20190331_pre.xml EX-101.PRE 336501
11 EXTRACTED XBRL INSTANCE DOCUMENT dvax-10q_20190331_htm.xml XML 1610391
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 19810648
SIC: 2834 Pharmaceutical Preparations